Pharmaceuticals by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Grifols has the lowest figure of the 50 pharmaceuticals ranked by P/S ratio, at 0.7, followed by Viatris (1.7) and GSK (2.3). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 50
- Lowest
- Grifols0.7
- Median
- 7.0
- Combined market value
- TRY 259.51T
- Countries
- 10
- Not ranked
- 11no P/S ratio on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | GrifolsGRFS · Health Care | 0.7 | TRY 296.2B | TRY 435.29 | 0.00% | 1% up | ||
| 2 | ViatrisVTRS · Health Care | 1.7 | TRY 1.19T | TRY 1,038.79 | 0.71% up | 96% up | ||
| 3 | GSKGSK · Health Care | 2.3 | TRY 4.98T | TRY 2,482.59 | 0.01% down | 6% up | ||
| 4 | SanofiSNY · Health Care | 2.4 | TRY 5.76T | TRY 2,398.36 | 0.04% up | 4% down | ||
| 5 | Takeda PharmaceuticalTAK · Health Care | 2.4 | TRY 3.47T | TRY 1,085.69 | 0.55% down | 54% up | ||
| 6 | Amneal PharmaceuticalsAMRX · Health Care | 2.5 | TRY 376.2B | TRY 1,079.75 | 1.36% up | 83% up | ||
| 7 | Bristol-Myers SquibbBMY · Health Care | 2.6 | TRY 6.28T | TRY 3,073.23 | 0.73% down | 34% up | ||
| 8 | PfizerPFE · Health Care | 2.6 | TRY 8.18T | TRY 1,435.74 | 0.02% up | 14% up | ||
| 9 | Elanco Animal HealthELAN · Health Care | 2.8 | TRY 665.8B | TRY 1,332.09 | 2.17% up | 20% up | ||
| 10 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.9 | TRY 2.52T | TRY 2,159.23 | 0.47% up | 74% up | ||
| 11 | PTC TherapeuticsPTCT · Health Care | 2.9 | TRY 253.8B | TRY 3,037.67 | 0.22% down | 20% down | ||
| 12 | Legend BiotechLEGN · Health Care | 3.2 | TRY 164.3B | TRY 846.87 | 4.22% up | 42% down | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | TRY 628.2B | TRY 753.55 | 0.95% up | 5% up | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | 3.5 | TRY 576.2B | TRY 2,974.87 | 0.80% up | 11% up | ||
| 15 | ZoetisZTS · Health Care | 3.6 | TRY 1.72T | TRY 4,240.38 | 0.71% up | 29% down | ||
| 16 | Jazz PharmaceuticalsJAZZ · Health Care | 3.6 | TRY 777.9B | TRY 12,119.66 | 0.18% down | 37% up | ||
| 17 | Novo NordiskNVO · Health Care | 3.9 | TRY 8.97T | TRY 2,035.45 | 0.86% down | 17% down | ||
| 18 | Abbott LaboratoriesABT · Health Care | 4.1 | TRY 9.15T | TRY 5,281.18 | 0.05% down | 17% down | ||
| 19 | AstraZenecaAZN · Health Care | 4.8 | TRY 14.15T | TRY 9,123.10 | 0.74% down | 2% up | ||
| 20 | Ionis PharmaceuticalsIONS · Health Care | 4.9 | TRY 231B | TRY 1,387.06 | 2.00% up | 64% down | ||
| 21 | AlkermesALKS · Health Care | 5.3 | TRY 391.5B | TRY 2,330.02 | 1.64% up | 58% up | ||
| 22 | Merck & CoMRK · Health Care | 5.3 | TRY 17.48T | TRY 7,092.19 | 1.95% down | 51% up | ||
| 23 | NovartisNVS · Health Care | 5.5 | TRY 15.01T | TRY 7,947.12 | 1.01% down | 25% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | 5.6 | TRY 1.06T | TRY 7,889.12 | 0.06% down | 66% down | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | 7.0 | TRY 5.03T | TRY 48,666.79 | 0.74% up | 36% up | ||
| 26 | Johnson & JohnsonJNJ · Health Care | 7.1 | TRY 33.8T | TRY 14,041.13 | 0.16% down | 38% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | 7.3 | TRY 307.2B | TRY 2,173.15 | 0.22% up | 10% up | ||
| 28 | United TherapeuticsUTHR · Health Care | 7.8 | TRY 1.26T | TRY 29,469.06 | 0.03% up | 23% up | ||
| 29 | AbbVieABBV · Health Care | 8.4 | TRY 26T | TRY 14,709.44 | 0.42% down | 26% up | ||
| 30 | GenmabGMAB · Health Care | 8.6 | TRY 1.62T | TRY 2,619.28 | 0.06% down | 70% up | ||
| 31 | BeOne MedicinesONC · Health Care | 8.8 | TRY 2.36T | TRY 20,662.72 | 0.87% down | 17% up | ||
| 32 | Travere TherapeuticsTVTX · Health Care | 10.0 | TRY 246.8B | TRY 2,571.36 | 0.23% down | 44% up | ||
| 33 | Corcept TherapeuticsCORT · Health Care | 10.2 | TRY 390B | TRY 3,563.75 | 0.83% up | 8% down | ||
| 34 | Madrigal PharmaceuticalsMDGL · Health Care | 10.2 | TRY 492.7B | TRY 21,208.46 | 0.36% down | 24% down | ||
| 35 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.2 | TRY 381.8B | TRY 4,859.56 | 1.30% up | 126% up | ||
| 36 | Axsome TherapeuticsAXSM · Health Care | 11.3 | TRY 362.5B | TRY 6,890.94 | 0.49% up | 7% down | ||
| 37 | Vertex PharmaceuticalsVRTX · Health Care | 11.3 | TRY 6.85T | TRY 27,004.88 | 0.22% up | 27% up | ||
| 38 | Mirum PharmaceuticalsMIRM · Health Care | 11.5 | TRY 301.4B | TRY 4,616.65 | 0.46% down | 31% up | ||
| 39 | TG TherapeuticsTGTX · Health Care | 15.6 | TRY 483.9B | TRY 3,201.54 | 1.22% up | 107% up | ||
| 40 | Royalty PharmaRPRX · Health Care | 16.6 | TRY 2T | TRY 3,472.20 | 0.23% up | 78% up | ||
| 41 | Eli LillyLLY · Health Care | 19.4 | TRY 63.65T | TRY 71,462.56 | 0.10% up | 35% up | ||
| 42 | Ligand PharmaceuticalsLGND · Health Care | 22.2 | TRY 299.9B | TRY 14,993.91 | 1.18% up | 43% up | ||
| 43 | Ascendis PharmaASND · Health Care | 22.3 | TRY 896.7B | TRY 13,670.91 | 0.06% down | 28% up | ||
| 44 | BridgeBio PharmaBBIO · Health Care | 29.9 | TRY 756.8B | TRY 3,884.79 | 0.29% up | 17% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | 42.3 | TRY 405.3B | TRY 5,846.35 | 0.60% down | 13% up | ||
| 46 | InsmedINSM · Health Care | 44.2 | TRY 1.35T | TRY 6,157.56 | 0.18% up | 40% down | ||
| 47 | CytokineticsCYTK · Health Care | 82.4 | TRY 365.8B | TRY 2,625.59 | 0.78% up | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | 179 | TRY 414.6B | TRY 6,352.75 | 1.03% up | 46% up | ||
| 49 | Dianthus TherapeuticsDNTH · Health Care | 2414 | TRY 247.9B | TRY 4,402.79 | 0.36% up | 113% up | ||
| 50 | Roivant SciencesROIV · Health Care | 3409 | TRY 1.42T | TRY 1,959.92 | 0.38% up | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4387 TRY). 11 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which pharmaceuticals have the lowest P/S ratio?
Grifols (0.7), Viatris (1.7) and GSK (2.3) have the lowest P/S ratio of the 50 pharmaceuticals ranked here as of 18 Nov 2026, 14:39 UTC.
How many pharmaceuticals are in this ranking?
50 are ranked by P/S ratio. 11 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 50 pharmaceuticals ranked by P/S ratio have a combined market value of TRY 259.51T as of 18 Nov 2026, 14:39 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.